A microencapsulated blend ensures high stability and effective delivery to the intestines, where live bacteria support microbiota balance, proper functioning of the digestive system, and natural immunity. This is a synbiotic in practice – a combination of probiotic strains with an exceptionally effective source of prebiotic, ideal for everyday support of gut health.
Supports gut microbiota balance thanks to five Bifidobacterium strains (BR03, BS01, BB01, BI02, BL03).
Enhances intestinal comfort and reduces symptoms related to bloating and intestinal discomfort.
Facilitates proper digestion and better utilisation of nutrients.
Supports regular bowel movements and maintenance of a proper intestinal rhythm.
Increases intestinal barrier integrity, which positively affects overall peristalsis and immunity.
Strengthens the natural immune response thanks to harmonious intestinal function.
Works synergistically by combining probiotics with the Fibregum Bio LAW prebiotic (synbiotic).
Microencapsulation increases probiotic stability and their survival in the digestive tract.
Simple, everyday supplementation in convenient capsule form (easy to fit into a daily routine).
Natural composition and a thoughtful set of strains supporting microbiota diversity.
May be helpful in stressful situations, travel, and dietary changes that affect the intestines.
Safe for most adults, with a recommendation to consult a doctor in specific circumstances (pregnancy, immunosuppression, severe illnesses).
Bifidobacterium breve BR03
Supports a healthy intestinal microbiota. Studies on BR03 (and BR03 in combination with other strains) often observe intestinal colonisation and competition with pathogens, modulation of the immune response (potential anti-inflammatory effect), support for the intestinal barrier and proper intestinal transit. Some studies are accompanied by improvements in metabolic parameters in obesity (in the BR03 + B632 duo) and a potential effect on insulin sensitivity.
A study in adolescents with obesity shows the strain’s effectiveness in regulating metabolic rate: BR03 + B632 and improved insulin sensitivity (confirming BR03 activity) [Clinical Nutrition / PubMed 34229263].
Bifidobacterium animalis lactis BS01
General characteristics of B. lactis include the ability to survive the stomach’s acidic environment and reach the intestine, support the intestinal barrier, and modulate the immune system. Benefits are often observed in reducing episodes of antibiotic-associated diarrhoea and improving regularity.
Bifidobacterium bifidum BB01
Participates in carbohydrate metabolism and production of short-chain fatty acids, supports intestinal barrier integrity and modulation of inflammation. A favourable effect on gut health is often observed, especially in combination with other strains.
Bifidobacterium infantis BI02
Important in the development and maintenance of the intestinal barrier (infantis strains are adapted to early development of the digestive system). Some BI strains are studied for alleviating intestinal inflammation and regulating the immune response.
Bifidobacterium longum BL03
Supports the intestinal barrier and has anti-inflammatory effects. May support microbiota stability and proper intestinal motility. Some studies associate B. longum with benefits in IBS and other intestinal disorders.
Each of the strains used has been carefully studied, providing evidence for the effectiveness of the blend.
Strain diversity may lead to better coverage of different niches in the intestines – adhesion to the mucosa, competition with pathogens, diverse metabolic activities, joint action on the intestinal barrier (reduced permeability) and modulation of the immune system, as well as joint enhancement of colonisation and maintenance of microbiota balance.
Multi-strain Bifidobacterium blends are commonly considered safe for most adults and are also used in pregnant women after consulting a doctor. However, individual responses may vary, and it is always worth consulting supplementation with a professional, especially in the context of chronic diseases, pregnancy, or immunosuppression.
Adults with intestinal ailments related to variable bowel function (e.g., mild tension and dyspeptic symptoms, sometimes IBS) – in the context of general support for microbiota balance.
People after antibiotic therapy – to rebuild intestinal bacterial flora faster.
People seeking support for the intestinal barrier and the immune system in the daily diet.
Pregnant and breastfeeding women – the decision to use should be made by the attending physician; bifidobacteria blends are often well tolerated, but safety depends on individual health circumstances.
The description refers to research presented in the following publications:
Supplementation with Bifidobacterium breve BR03 and B632 strains improved insulin sensitivity in children and adolescents with obesity in a cross-over, randomised double-blind placebo-controlled trial PMID: 34229263
Recent Development of Probiotic Bifidobacteria for Treating Human Diseases PMCID: PMC8727868
Therapeutic Microbiology: The Role of Bifidobacterium breve as a Food Supplement for the Prevention/Treatment of Paediatric Diseases https://doi.org/10.3390/nu10111723
Symptoms that may indicate the need for probiotic therapy (after medical or dietetic consultation):
Your review appreciation cannot be sent
Report comment
Report sent
Your report cannot be sent
Write your review
Review sent
Your review cannot be sent
Customers who bought this product also bought:
DHEA male 25 mg, 60 capsules
Fearless Dream, UNBREAKABLE...
Thymosin alpha-1 5 mg
Triphala 500 mg, 60 capsules
BPC-157 HCl 100 mcg, 60...
Black cohosh 300 mg, 60...
E-book Peptides and...
Alpha-lipoic acid 600 mg,...
Newsletter
Get a discount on your first order
We specialize in wholesale and retail supplies of high-quality supplements, peptides, sarms, amino acids, nootropics and adaptogens.
Category
Offer
Our company
E-mail address
info@biolabshop.euWhatsApp
+44 739 8562 456